Navigation Links
New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
Date:5/5/2008

- Studies Evaluated Improvement in Symptoms Both in the Short and Long Term

-

WILMINGTON, Del., May 5 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced new study data on SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD) in adult patients. The results from the studies were presented today at the 161st Annual Meeting of the American Psychiatric Association (APA) in Washington, DC. In February 2008, the company submitted a supplemental new drug application (sNDA) for SEROQUEL XR for the treatment of MDD as monotherapy, adjunct therapy, and maintenance therapy. AstraZeneca plans to submit a sNDA for SEROQUEL XR for the treatment of GAD, including maintenance of antianxiety effect, during the second quarter of 2008.

The SEROQUEL XR clinical development programs for MDD and GAD included seven Phase III, placebo-controlled studies in MDD as well as four Phase III, placebo-controlled studies in GAD. The three MDD studies presented today investigated SEROQUEL XR in the treatment of adult patients diagnosed with MDD-as monotherapy in both short-term and maintenance treatment and as short- term adjunct treatment versus placebo.(1-3) The two GAD studies presented today investigated treatment with SEROQUEL XR in adult patients diagnosed with GAD-as monotherapy in both short-term and maintenance treatment versus placebo.(4,5) Across all MDD and GAD studies presented today, efficacy with SEROQUEL XR was superior to placebo, as assessed by the primary endpoints. In addition, adverse events reported for SEROQUEL XR in these studies were generally similar to those reported in previous clinical trials with quetiapine (See detailed study data below).(1-5)

MDD affects approximately 15 million American adults and studies have shown that at least one-third of patients with MDD treated with antidepressants fa
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
2. SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
3. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
4. Keppra XR(TM) Extended-Release Tablets Filed with the FDA
5. UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
6. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
7. Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer
8. Data Show Preoperative Assessment of Breast Cancer Patients Enables Early Diagnosis, Successful Treatment of Lymphedema
9. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
10. ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
11. Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... DUBLIN , Mar. 30, 2015 Research ... announced the addition of the "Eurpoean Automatic ... Fully-Automated), End-User (Pre-Hospitals, Public Access Market, Hospitals, Alternate ... report to their offering. The European ... grow at a CAGR of 10.9% from 2014 ...
(Date:3/31/2015)... , March 31, 2015  The efficacy of ... highlighted in a recently published study 1 of ... prevention research team, including Curtis Donskey , M.D.  ... run for the same length of time from the ... (PU-UV) unit.  The results showed surprisingly low pathogen kill ...
(Date:3/31/2015)... DALLAS , March 31, 2015 ... H1 2015" therapeutic market research report of 68 ... its online business intelligence library. The ... information on the therapeutic development for Pemphigus ... therapeutics assessment by drug target, mechanism of action ...
Breaking Medicine Technology:Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 2Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4
... antibody successfully targets human leukemic stem cells, ... company, has today presented data at the American ... the promising,pre-clinical activity of a novel monoclonal antibody, ... AML is an aggressive cancer of white ...
... Scientific Presentations Detail Progress with VeraTag(TM) Assays in Breast ... ... (Nasdaq: MGRM ) today announced five posters to be,presented at the 30th ... - 16, 2007. Following are details for,each embargoed session:, -- Friday, ...
Cached Medicine Technology:Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML) 2Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML) 3Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium 2Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium 3
(Date:3/31/2015)... March 31, 2015 Many people, including ... basketball, rock climbing, and cycling are only for able-bodied ... at Memorial Rehabilitation Institute aims to change that thinking. ... System, will host an Adaptive Sports Expo on Saturday, ... Regional Hospital South in Hollywood. , The event ...
(Date:3/31/2015)... 2015 On March 26, 2015, Vogue Magazine ... Silicone Slope?” provides a look into the trend of young ... laser treatments . The article suggests that celebrity endorsements ... such as Kim Kardashian and Kylie Jenner are the drivers ... seen as significant influences on the self-esteem of teenagers. (see: ...
(Date:3/31/2015)... Dr. Russell Ashinoff is a plastic and reconstructive surgeon ... quoted in an Asbury Park Press article about Lymphedema. ... and tissue swelling. Dr. Ashinoff is one of few ... lymphedema symptoms. , “The goal of our surgical ... The goal is to improve the intrinsic drainage of ...
(Date:3/31/2015)... 2015 Beckman Coulter is sponsoring a ... “Subvisible Particulate Matter in Therapeutic Protein Injections”,” an educational session ... in counting particles in liquids, with a focus on the ... free to attend and will be broadcast live April 8, ... new test for protein-based materials, known as USP 787 ...
(Date:3/31/2015)... National Adaptive Sports Month will increase ... of participating in adaptive sports activities, educate the ... that adapt, believe and compete each week in ... and inclusive athletics in our schools, provide information ... and advocate for an increase in the financial ...
Breaking Medicine News(10 mins):Health News:Memorial Healthcare System's Adaptive Sports Expo Encourages Physically Challenged To Go Beyond Perceived Limitations 2Health News:Cosmetic Surgery: Does Social Media Pressure Young Girls to Get Botox and Fillers? 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 3Health News:April is National Adaptive Sports Month 2Health News:April is National Adaptive Sports Month 3
... of genes that are safely ensconced in the systematic pattern of ... genes in the human genome are in an alert state in ... dormant state. ,This trait of genes, called gene silencing ... cover for the genome from viruses, and even cancer, and is ...
... According to a new study, it has been found that the ... trans fat, which is never the // same and varies from ... colleagues in the April 13 issue of The New England Journal ... from less than 1 gram in Denmark and Germany, to 10 ...
... doctors have been forced to disclose details about their out ... by the Federal Government. In an attempt to encourage young ... further planned to abolish the two five percent lifetime surcharge ... accompanied by the sale of Medibank Private, would be unveiled ...
... In what can be called as an extreme act of generosity, ... who had shot her and shattered her spine//, three years back. ... what he had done to her was wrong. ,The ... recovered after she sipped a glass of outer. In her subtle ...
... a swan in Fife, Scotland health officials are making the ... would offer protection against the seasonal bird flu. ... to the highly susceptible group just as farmers and poultry ... virus into a more virulent form, capable of sparking a ...
... use unhealthy weight-control behaviors at an increased risk of being ... at the // University of Minnesota. Their study, which appears ... Dietetic Association, says that adolescents with unhealthy weight-control behaviors are ... years. ,The use of diet pills, laxatives, and ...
Cached Medicine News:Health News:Novel method conceived, to achieve genome-wide gene silencing. 2Health News:Fat Content In McDonald’s & KFC's Foods Varies From Country To Countr 2Health News:Fat Content In McDonald’s & KFC's Foods Varies From Country To Countr 3Health News:Doctors to Reveal Gap Fees Charges to Patients 2Health News:Poultry Workers in Scotland to Be Vaccinated For Bird Flu 2
... Leica ASP300 smart tissue processor features superior ... ASP300 is a fully enclosed, stand-alone system ... samples. This new tissue processor combines proven ... touch screen and easy to use,yet powerful ...
... 120 represents a new tissue infiltration instrument, ... a masterly way. The robust caroussel design ... smallest space. The instrument includes either 10 ... reagent and 3 paraffin containers. Up to ...
... electronic, motorized rotary microtomes ... applications of paraffin, semi-thin ... specimens in clinical, research, ... instruments display extra-ordinary ergonomic ...
... heavy-duty sectioning system is the standard microtome for ... real working animal. ,Large specimens up to 250 ... bone or teeth and whole organs (brain, lung, ... accessories, specially designed for paraffin and resin embedded ...
Medicine Products: